These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14185015)

  • 21. ANALYSIS OF MECHANISM OF IMMUNOSUPPRESSIVE DRUGS IN RENAL HOMOTRANSPLANTATION.
    MURRAY JE; SHEIL AG; MOSELEY R; KNIGHT P; MCGAVIC JD; DAMMIN GJ
    Ann Surg; 1964 Sep; 160(3):449-73. PubMed ID: 14206850
    [No Abstract]   [Full Text] [Related]  

  • 22. [Influence of histidine and its metabolites on the biosynthesis of purines by Escherichia coli B. IV. Action on some cultures inhibited by azaserine].
    HEDEGAARD J; MASPERO SEGRE S; NGUYEN VAN THOAI ; ROCHE J
    C R Seances Soc Biol Fil; 1959; 153():767-71. PubMed ID: 14400512
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of histidine and of its metabolites on the biosynthesis of purines by Escherichia coli B. V. Mode of action in cultures inhibited by azaserine].
    HEDEGAARD J; MASPERO-SEGRE S; NGUYEN VAN THOAI ; ROCHE J
    C R Seances Soc Biol Fil; 1959; 153():767-71. PubMed ID: 13848416
    [No Abstract]   [Full Text] [Related]  

  • 24. EVIDENCE FOR THE SYNTHESIS OF THE "DIVISION PROTEIN" IN TETRAHYMENA PYRIFORMIS.
    WATANABE Y; IKEDA M
    Exp Cell Res; 1965 May; 38():432-4. PubMed ID: 14284523
    [No Abstract]   [Full Text] [Related]  

  • 25. CROSS RESISTANCE AND COLLATERAL SENSITIVITY STUDIES IN CANCER CHEMOTHERAPY.
    HUTCHISON DJ
    Adv Cancer Res; 1963; 7():235-50. PubMed ID: 14153767
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of the biosynthesis of purines de novo by 6-chloropurine and azaserine in sensitive and naturally resistant ascites cells.
    SARTORELLI AC; AKERS JR; BOOTH BA
    Biochem Pharmacol; 1960 Nov; 5():238-44. PubMed ID: 13746609
    [No Abstract]   [Full Text] [Related]  

  • 27. Utilization of preformed purines by sarcoma 180 or hepatoma 134 cells treated with 6-chloropurine or a combination of 6-chloropurine and azaserine.
    SARTORELLI AC; BOOTH BA
    Biochem Pharmacol; 1960 Nov; 5():245-50. PubMed ID: 13746610
    [No Abstract]   [Full Text] [Related]  

  • 28. FOCAL DEGRADATION AS A BIOLOGICAL PROCESS.
    SWIFT H; HRUBAN Z
    Fed Proc; 1964; 23():1026-37. PubMed ID: 14209794
    [No Abstract]   [Full Text] [Related]  

  • 29. TETRAHYMENA CELLS IN THE G2 PHASE-SENSITIVITY TO TEMPERATURE AND TO INHIBITORS OF PROTEIN SYNTHESIS.
    ZEUTHEN E
    J Cell Comp Physiol; 1963 Oct; 62():SUPPL1:148-56. PubMed ID: 14067860
    [No Abstract]   [Full Text] [Related]  

  • 30. UNICELLULAR ORGANISMS AS MODEL SYSTEMS FOR THE MODE OF ACTION OF PHENOTHIAZINE AND RELATED DRUGS.
    FORREST IS; QUESADA F; DEITCHMAN GL
    Proc West Pharmacol Soc; 1964; 7():42-4. PubMed ID: 14185237
    [No Abstract]   [Full Text] [Related]  

  • 31. THE EFFECTS OF ACTINOMYCIN D ON STOMATOGENESIS AND CELL DIVISION IN TEMPERATURE-SYNCHRONIZED TETRAHYMENA PYRIFORMIS.
    WHITSON GL; PADILLA GM
    Exp Cell Res; 1964 Dec; 36():667-71. PubMed ID: 14242251
    [No Abstract]   [Full Text] [Related]  

  • 32. ENHANCEMENT OF THIOINOSINATE SYNTHESIS IN THE EHRLICH ASCITES CARCINOMA BY PRIOR TREATMENT WITH 6-MERCAPTOPURINE OR AZASERINE.
    PATERSON AR
    Acta Unio Int Contra Cancrum; 1964; 20():1033-6. PubMed ID: 14274687
    [No Abstract]   [Full Text] [Related]  

  • 33. METABOLIC EFFECTS OF 9-BUTYL-6-THIOGUANINE IN VIVO.
    KIMBALL AP; LEPAGE GA
    Cancer Res; 1963 Dec; 23():1792-9. PubMed ID: 14082874
    [No Abstract]   [Full Text] [Related]  

  • 34. [RECENT TRENDS IN ANTICARCINOGENIC ANTIBIOTICS].
    UMEZAWA H
    Naika; 1964 Jun; 13():1091-6. PubMed ID: 14172451
    [No Abstract]   [Full Text] [Related]  

  • 35. On the mechanism of action of antibiotics which act as irreversible enzyme inhibitors.
    Rando RR
    Biochem Pharmacol; 1975 Jun; 24(11-12):1153-60. PubMed ID: 1137602
    [No Abstract]   [Full Text] [Related]  

  • 36. Antineoplastic activity of combinations of 6-chloropurine and azaserine.
    SARTORELLI AC; BOOTH BA
    Cancer Res; 1960 Feb; 20():198-203. PubMed ID: 14441824
    [No Abstract]   [Full Text] [Related]  

  • 37. [ANTIBIOTICS AND NUCLEIC ACIDS].
    TANAKA N
    Sogo Igaku; 1963 Dec; 20():867-73. PubMed ID: 14100272
    [No Abstract]   [Full Text] [Related]  

  • 38. THE UPTAKE OF FUANINE, URACIL, LYSINE AND GLYCINE BY ASCITES CELLS PRETREATED WITH AZASERINE AND 6-THIOGUANINE.
    ADAMS DH
    Biochem J; 1963 Nov; 89(2):240-8. PubMed ID: 14084607
    [No Abstract]   [Full Text] [Related]  

  • 39. The stoichiometric fate of azaserine metabolized in vitro by tissues from azaserine-treated dogs and mice.
    Rosenkrantz H; Sprague R; Schaeppi U; Pittillo RF; Cooney DA; Davis RD
    Toxicol Appl Pharmacol; 1972 Aug; 22(4):607-20. PubMed ID: 5045765
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemotherapy of sarcoma 180 by combinations of DL-glyceraldehyde with 6-thioguanine or with azaserine and 6-chloro-purine.
    SARTORELLI AC; SCHOOLAR EJ; KRUSE PF
    Proc Soc Exp Biol Med; 1960 Jun; 104():266-8. PubMed ID: 14441826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.